ATLAS / Macro Radar / Reporting / NVCT

Nuvectis Pharma, Inc. (NVCT) reporting calendar

Nuvectis Pharma, Inc. files periodic reports with the SEC as NVCT on Nasdaq. Atlas tracks 18 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
26 Jul 2026 – 15 Aug 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
5 May 2026
Reports on record
18

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 36 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open NVCT market profile Latest filing on SEC EDGAR ↗ Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 20265 May 202635 days0001104659-26-055318
10-K31 Dec 202511 Feb 202642 days0001104659-26-013044
10-Q30 Sep 20254 Nov 202535 days0001104659-25-105939
10-Q30 Jun 20255 Aug 202536 days0001558370-25-010203
10-Q31 Mar 20256 May 202536 days0001558370-25-006497
10-K31 Dec 202425 Feb 202556 days0001558370-25-001496
10-Q30 Sep 20245 Nov 202436 days0001558370-24-014340
10-Q30 Jun 20246 Aug 202437 days0001558370-24-010971
10-Q31 Mar 20247 May 202437 days0001558370-24-007072
10-K31 Dec 20235 Mar 202465 days0001558370-24-002497
10-Q30 Sep 20238 Nov 202339 days0001558370-23-018124
10-Q30 Jun 20239 Aug 202340 days0001558370-23-014266
10-Q31 Mar 202310 May 202340 days0001558370-23-009133
10-K31 Dec 20228 Mar 202367 days0001558370-23-003181
10-Q30 Sep 20228 Nov 202239 days0001558370-22-016755
10-Q30 Jun 202210 Aug 202241 days0001558370-22-013018
10-Q31 Mar 202212 May 202242 days0001410578-22-001377
10-K31 Dec 202123 Mar 202282 days0001104659-22-037110

Source: SEC EDGAR company submissions for CIK 0001875558. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.